Measuring prions by bioluminescence imaging.
Prions are infectious proteins that cause fatal neurodegenerative diseases. Because astrocytic gliosis marked by the deposition of fibrils composed of GFAP is a prominent feature of prion disease, we asked whether GFAP might be used as a surrogate marker for prions. To interrogate this posit, we inoculated prions into transgenic (Tg) mice expressing luciferase (luc) under the GFAP gene (Gfap) promoter, denoted Tg(Gfap-luc) mice. Weekly noninvasive, bioluminescence imaging (BLI) detected an increase in light emitted from the brains of Tg(Gfap-luc) mice at approximately 55 d after inoculation and approximately 62 d before neurologic deficits appeared. To determine whether BLI could be used as a proxy bioassay for prion infectivity, we performed endpoint titrations of prions in Tg(Gfap-luc) mice. BLI bioassays were as or more sensitive than those determined by the onset of neurological dysfunction, and were completed in approximately half the time. Our studies argue that BLI is likely to be a suitable surrogate for measuring prion infectivity, and might be useful in the study of Tg mouse models for other neurodegenerative illnesses.
Tamgüney
Gültekin
G
Institute for Neurodegenerative Diseases and Department of Neurology, University of California, San Francisco, CA 94143, USA.
Francis
Kevin P
KP
Giles
Kurt
K
Lemus
Azucena
A
DeArmond
Stephen J
SJ
Prusiner
Stanley B
SB
D000818:Animals; D004195:Disease Models, Animal; D017930:Genes, Reporter; D007150:Immunohistochemistry; D008156:Luciferases / Q000235:genetics / Q000378:metabolism; D008163:Luminescent Measurements / Q000379:methods*; D051379:Mice; D008822:Mice, Transgenic; D017096:Prion Diseases / Q000378:metabolism* / Q000473:pathology; D011328:Prions / Q000032:analysis* / Q000378:metabolism
D011328:Prions; D008156:Luciferases
J Virol. 1994 Apr;68(4):2383-7
8139024
Neuropathol Appl Neurobiol. 2002 Apr;28(2):107-19
11972797
Lancet. 1961 Jun 24;1(7191):1378-9
13692303
J Gen Virol. 1986 Feb;67 ( Pt 2):255-63
3080549
Braz J Med Biol Res. 1999 May;32(5):619-31
10412574
J Virol. 2000 Jan;74(1):320-5
10590120
Proc Natl Acad Sci U S A. 2003 Sep 30;100(20):11666-71
14504404
Ann Neurol. 1982 Apr;11(4):353-8
6808890
Proc Natl Acad Sci U S A. 1987 Aug;84(16):5937-41
2441399
Neurosci Lett. 2004 Sep 2;367(2):210-2
15331155
Nat Rev Microbiol. 2004 Nov;2(11):861-71
15494743
Proc Natl Acad Sci U S A. 1992 Aug 15;89(16):7620-4
1354357
Proc Natl Acad Sci U S A. 1994 Jun 7;91(12):5690-4
7911243
Brain Res. 1997 Apr 18;754(1-2):171-80
9134973
Stroke. 2008 Mar;39(3):935-42
18258827
Annu Rev Pathol. 2008;3:11-40
18233951
Nature. 1984 Aug 2-8;310(5976):418-21
6431296
Science. 1982 Dec 24;218(4579):1309-11
6815801
Neurobiol Aging. 2002 Jan-Feb;23(1):59-64
11755020
Glia. 2009 Aug 1;57(10):1130-42
19115383
Biochemistry. 1980 Oct 14;19(21):4883-91
6775697
Br Med Bull. 2003;66:1-20
14522845
Mol Syst Biol. 2009;5:252
19308092
Nat Med. 1997 Jul;3(7):750-5
9212101
Mol Cell Biol. 1988 Dec;8(12):5528-40
3149717
J Neuroinflammation. 2008 Feb 01;5:6
18237444
Nature. 2006 Oct 19;443(7113):803-10
17051207
Neurology. 1991 Sep;41(9):1482-90
1679911
Brain Pathol. 1994 Jul;4(3):259-75
7952267
J Gen Virol. 2008 Jul;89(Pt 7):1777-1788
18559949
Mov Disord. 2008 Mar 15;23(4):474-83
18044695
Infect Immun. 2005 Dec;73(12):7836-43
16299273
Neurology. 1996 Aug;47(2):449-53
8757019
Lancet. 1984 Aug 11;2(8398):345
6146882
Proc Natl Acad Sci U S A. 1996 Sep 3;93(18):9754-8
8790403
Brain Res Dev Brain Res. 1995 Apr 18;85(2):181-6
7600665
Am J Pathol. 2004 Aug;165(2):671-8
15277240
J R Soc Med. 1982 Aug;75(8):618-24
6809940
Cell. 1989 Dec 1;59(5):847-57
2574076
Brain Res. 1984 Aug;317(2):201-9
6383523
J Virol. 2000 May;74(9):4377-86
10756052
Science. 1982 Apr 9;216(4542):136-44
6801762
Cell. 1993 Jun 4;73(5):979-88
8098995